norethindrone acetate has been researched along with Polycystic Ovarian Syndrome in 2 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amenorrhea is a clinical condition characterized by failure of menarche or by the absence of menstruation for six months in a woman with previous periodic menses." | 1.31 | Cyclic estrogen-progestin hormone therapy as a new therapeutic approach in the treatment of functional alterations of the hypothalamus-pituitary-ovary axis: case reports. ( Russo, P; Trimarchi, CP, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caserta, D | 1 |
| Matteucci, E | 1 |
| Ralli, E | 1 |
| Mallozzi, M | 1 |
| Bordi, G | 1 |
| Moscarini, M | 1 |
| Trimarchi, CP | 1 |
| Russo, P | 1 |
2 other studies available for norethindrone acetate and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
A 29-year-old woman with complex atypical hyperplasia and polycystic ovary syndrome: a challenging issue.
Topics: Adult; Endometrial Hyperplasia; Female; Fertility Preservation; Humans; Norethindrone; Norethindrone | 2014 |
Cyclic estrogen-progestin hormone therapy as a new therapeutic approach in the treatment of functional alterations of the hypothalamus-pituitary-ovary axis: case reports.
Topics: Adenoma; Adult; Amenorrhea; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Feed | 2002 |